NDC product
SOLUTION, CONCENTRATE · SUCAMPO PHARMA LIMITED LIABILITY COMPANY
NDC 13299-0102 · SUCAMPO PHARMA LIMITED LIABILITY COMPANY
Key facts
| Product NDC | 13299-0102 |
|---|---|
| Nonproprietary name | Lubiprostone Premix |
| Substances | LUBIPROSTONE |
| Dosage form | SOLUTION, CONCENTRATE |
| Labeler | SUCAMPO PHARMA LIMITED LIABILITY COMPANY |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Apr 1, 2010 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: